title: Somatostatin enhances insulin-stimulated glucose uptake in the perfused human forearm.
abstract: Somatostatin is widely used in experimental metabolic studies to control hormone actions. It has also been suggested that, in addition to its well known suppressive effects, somatostatin per se may increase insulin sensitivity. In order to examine this suggestion, we gave six healthy male volunteers (age 33 +/- 1 yr, mean +/- SEM; body mass index, 24.1 +/- 0.6 kg/m2) either a local intraarterial (brachial artery) or a systemic venous infusion of 25 micrograms/h somatostatin twice. The study consisted of a 1-h basal period and a 2-h systemic hyperinsulinemic (0.4 mU/kg.min) euglycemic clamp. Compared with the systemic control infusion, local forearm perfusion with somatostatin caused a 55% increase in insulin-stimulated forearm glucose uptake (0.74 +/- 0.18 vs. 0.47 +/- 0.19 mmol/L, P < 0.05). Intraarterial somatostatin perfusion did not alter basal forearm glucose uptake (0.14 +/- 0.07 vs. 0.17 +/- 0.12 mmol/L), the amount of glucose administered during the clamp (M-value, 3.2 +/- 0.5 vs. 3.0 +/- 0.6 mg/kg.min), or the levels of insulin, C-peptide, glucagon, or GH. Intermediary metabolite exchange across the forearm, total forearm blood flow, and oxygen saturations also remained stable. Glucose concentrations were slightly higher (0.06 +/- 0.01 mmol/L) in arterial than in arterialized blood, whereas lactate concentrations were comparatively decreased (108 +/- 51 mumol/L) in arterial blood. Our data suggest that somatostatin increases insulin-stimulated muscle utilization of glucose through local mechanisms. Although the nature of this increase remains to be established, it should be taken into consideration in metabolic studies using somatostatin.
authors.affiliation: Medical Department M (Endocrinology and Diabetes), Aarhus University Hospital, Denmark.
authors.forename: N
authors.initials: N
authors.lastname: Møller
authors.forename: J P
authors.initials: JP
authors.lastname: Bagger
authors.forename: O
authors.initials: O
authors.lastname: Schmitz
authors.forename: J O
authors.initials: JO
authors.lastname: Jørgensen
authors.forename: P
authors.initials: P
authors.lastname: Ovesen
authors.forename: J
authors.initials: J
authors.lastname: Møller
authors.forename: K G
authors.initials: KG
authors.lastname: Alberti
authors.forename: H
authors.initials: H
authors.lastname: Orskov
mesh_terms: D020155:3-Hydroxybutyric Acid; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D002096:C-Peptide / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005542:Forearm / Q000098:blood supply*; D005934:Glucagon / Q000097:blood; D015309:Glucose Clamp Technique; D005990:Glycerol / Q000097:blood; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D006885:Hydroxybutyrates / Q000097:blood; D007261:Infusions, Intra-Arterial; D007328:Insulin / Q000097:blood / Q000494:pharmacology*; D008297:Male; D013004:Somatostatin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*
chemical_list: D001786:Blood Glucose; D002096:C-Peptide; D005230:Fatty Acids, Nonesterified; D006885:Hydroxybutyrates; D007328:Insulin; D013004:Somatostatin; D013006:Growth Hormone; D005934:Glucagon; D005990:Glycerol; D020155:3-Hydroxybutyric Acid